logo
Sign in

BVS Stock Price, Chart, Stats & News

Bioventus Inc.
Save
612.44M
Market cap
22.05x
Current P/E
10.24x
Forward P/E

BVS chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
67.32%
Operating margin
10.04%
Pretax margin
4.53%
Net margin
4.00%
Effective tax rate
-6.09%
ROA
3.33%
ROE
13.79%
D/E
1.69x
Interest coverage ratio
2.15x

BVS valuation

P/E
22.05x
P/S
1.06x
P/B
3.24x
P/CF
7.98x
P/FCF
8.35x
P/OCF
7.98x
PEG
0.14x
EV multiple
3.24x

About

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement.

Similar securities

Based on sector and market capitalization

Report issue